直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

USPTO Issues Memorandum Aligning Indefiniteness Standard with District Court

January 11, 2021

Authored and Edited by Brooke M Wilner; Amanda K. Murphy, Ph.D.

On January 6, 2021, the U.S. Patent & Trademark Office issued a memorandum to the Patent Trial and Appeal Board, requiring that, in post-grant trial proceedings, the Board must follow the same indefiniteness standard used in district courts.  The Board must now analyze indefiniteness in post-grant trial proceedings under the standard set forth in Nautilus, Inc. v. Biosig Instruments, Inc., 572 U.S. 898 (2014)—that is, a claim is indefinite if, read in light of the specification and the prosecution history, it fails to inform those skilled in the art about the scope of invention with reasonable certainty.  Id. at 901.

For many years, the Office and Board had used a different indefiniteness standard, approved by the Federal Circuit in In re Packard, 751 F.3d 1307 (Fed. Cir. 2014) (per curiam).  Under the Packard standard, a claim was indefinite “when it contains words or phrases whose meaning is unclear.”  Id. at 1310, 1314. 

In 2018, the Office changed the claim construction standard for post-grant trial proceedings.  The standard, which had previously required the “broadest reasonable construction” of terms, was changed to align with the same claim construction standard used to construe claims in district courts, namely that claims should be construed pursuant to Philips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc).  See Changes to the Claim Construction Standard for Interpreting Claims in Trial Proceedings Before the Patent Trial and Appeal Board, 83 Fed. Reg. 51340 (Oct. 11, 2018).  Since that change, the Board has in some cases shown confusion as to whether to apply the Nautilus or Packard standard to questions of indefiniteness.

The Office’s memorandum clarifies that the Packard standard no longer applies in post-grant trial proceedings.  Like the 2018 changes that changed the Board’s claim construction standard, the memorandum similarly changes the Board’s indefiniteness standard to align with that used in district courts.  Applying the Nautilus standard for indefiniteness to post-grant trial proceedings will, in the words of the memorandum, “lead to greater uniformity and predictability, improve the integrity of the patent system, and help increase judicial efficiency.”

Tags

United States Patent and Trademark Office (USPTO), indefiniteness (35 USC § 112), Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals to the PTAB

Patent Office Invalidation Proceedings

Related Offices

Atlanta, GA

Washington, DC

Contacts

Amanda K. Murphy, Ph.D.
Partner
London
+44 (0)20 7864 2814
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Conference

Best Practices and Tech in Intellectual Property Conference 2026

May 17, 2026

Tel Aviv

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP